Roberto de Ponti

Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland.

OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA.

Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA.

Roca Therapeutics SAS is a French company that engages in research and drug development in the fields of oncology, ophthalmology, and immunology. The company is based in Nice, France. The company was founded in 2021. The CEO is Maeva Dufies.

Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy.

3B Future Health Fund S.A. SICAR invest in companies located in Luxembourg. The fund targets companies operating in the fields of innovative technologies, cancer therapeutics & diagnostics, cancer supportive care, metabolic & gastrointestinal disorders, and dermatology conditions. It provides financing for early stage transactions.

GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland.

Indena SpA provides research and development of medicinal products from plants. It offers products to the pharmaceutical, health-food, and personal care industries. The firm provides anti-cancer drugs, which are produced to US-FDA, ICH and EU standards and manufacturing facilities. The company was founded in 1921 and is headquartered in Milan, Italy.